LYFNUA 45 mg Film-coated tablet

Licence status
Authorised: 15/09/2023
Active substances
Gefapixant
Dosage Form
Film-coated tablet
Licence number
EU/1/21/1613/001-004
Licence holder
Merck Sharp & Dohme BV,

Product documents

Licence information

ATC code
R05DB Other cough suppressants, R05DB29 gefapixant
Legal supply status
Product subject to prescription which may be renewed (B)
Place of sale
Supply through pharmacies only
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
15/09/2023